Innovation
Alsymo aims to treat patients with pulmonary hypertension
… Alsymo aims to treat patients with pulmonary hypertension Alsymo aims to treat … are focusing on a drug that acts on pulmonary vascular N-methyl-D-aspartate (NMDA) receptors. Approximately 50 out of … promising. Working hand in hand with the PAH reference centre "Our other advantage is that we are backed by the …
Published on: